Zepp Health Corporation Roars Back to Revenue Growth with 6.9% YoY Increase in Q2 2026, Highlighting Strong Adoption of Higher-End Products

Share
Zepp Health Corporation Roars Back to Revenue Growth with 6.9% YoY Increase in Q2 2026, Highlighting Strong Adoption of Higher-End Products


Zhongqi Zepp Health Corporation's second quarter 2026 earnings call brought forth a refreshing surprise as the company reported year-over-year revenue growth of 6.9%, reaching $63.5 million. This significant milestone marks a triumphant return to expansion, following a measured yet impressive gross margin improvement of 120 basis points from the same period last year.

The CEO, Mr. Wang Huang, expressed satisfaction with the company's performance, stating that the growth was achieved despite higher memory and other components' costs. Notably, Zepp has successfully navigated the market, launching or expanding products across their major families, each serving a distinct strategic role.

One of the key highlights from the quarter was the shift in product mix towards higher-value products within the T-Rex family. The introduction of high-end models such as the T-Rex 3 Pro and the T-Rex Ultra 2 has led to a consistent 50% share of recent global activations, demonstrating durable consumer acceptance of both the higher-end products and the broader T-Rex price ladders.

The Active family also showcased remarkable growth, with strict definitions used to track its performance. The introduction of Active 3 Premium and Active Max models positioned at a U.S. suggested retail price of $169 led to an increase in global activations from approximately 22% in the first quarter to around 40% in the second quarter. This figure further rose to approximately 49% in July and around 57% through August 25, 2026.

Perhaps the most impressive aspect was the Active family's ability to match the scale of Bip family activations, with both demonstrating broad comparability in monthly activations during July and August this year. This significant milestone not only highlights the successful expansion of a new price tier but also underscores Active's potential as a competitor to established products.

Zepp Health Corporation's quarterly performance has provided a compelling narrative of innovation and strategic growth, further cementing its position within the industry. As we continue to monitor their progress, one thing is certain – the company is well on its way to establishing itself as a significant player in the market.

Read more